AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 131 min read$WSE

UBS raises Wise price target 12% to 1,300p ahead of results

UBS raised its price target for Wise Group PLC (WISE, WSE) to 1,300p, up 12% from 1,160p, citing expected higher interest rates. The new target is 41.6% above Wise's recent closing price of 918p. UBS forecasts earnings per share of US$0.82 for 2028, driven by higher interest rates. Wise is set to report Q2 results on Thursday, with UBS expecting pre-tax profit margins above guidance.

Original reporting
finance.yahoo.com
Published Oct 13, 2026, 12:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 12:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
UBS raises Wise price target 12% to 1,300p ahead of results — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$WSEBullishMed
01

Why it matters

The price‑target increase signals a bullish outlook, potentially prompting short‑term buying interest.

02

Market read

Analyst upgrade may drive modest upside for Wise and similar fintech stocks.

03

What to watch

Potential slowdown in transaction volumes could offset margin benefits.

Relevance 7/10Novelty 7/10Timing: today

Background

Wise Group (NASDAQ:WSE) is a cross‑border payments provider; UBS upgraded its target based on projected interest‑rate driven earnings uplift.

Company-level read

Ticker impact

$WSEBullishHigh confidence
Context

UBS raised its price target on Wise Group to 1,300p, up 12% from 1,160p, citing higher interest‑rate forecasts.

Expected impact

likely upward pressure as investors price in higher earnings expectations

Evidence & confidence

The new target is 41.6% above the current price, indicating a strong bullish view from a major broker.

Market effects

Sector

Higher interest‑rate environment may benefit other cross‑border payment firms with large balance‑sheet assets.

Regional

UK‑listed fintechs could see modest gains as analysts adjust expectations.

Global

Limited to the fintech/payments sector; no broad market effect.

Counterpoint

What could challenge this read

If interest‑rate gains do not materialise, the higher target may be overly optimistic.

Key entities

  • analyst
    UBS

    Investment bank providing the upgraded target.

  • company
    Wise Group PLC

    Fintech firm receiving the upgraded target.

Read at source← All news

Related articles

JUL 21
$WSEMed

Wise Group plc launches share buyback program

Wise Group plc (Nasdaq: WSE, LSE: WISE) confirmed the start of a previously announced share buyback program. It hired Goldman Sachs International to repurchase Class A ordinary shares for up to £405 million (about $540 million), starting July 21, 2026 and ending by March 31, 2027. About 40% goes to an Employee Share Trust and 60% to treasury.

investegate.co.uk2 min
JUL 17
$WSEMedAI 8/10

Wise Q1 FY27 Trading Update

Wise Group plc reported Q1 FY27 results for the quarter ended June 30, 2026. Active customers rose 21% YoY to 11.9 million, cross-border volume increased 26% to $69.3B, and net revenue grew 25% to $714.0M. Customer holdings rose 31% to $41.2B. The cross-border take rate fell 2 bps to 50 bps. Wise reiterated FY27 guidance.

investegate.co.uk4 min
OCT 15
$IRDMedAI 9/10

Opus Genetics Presents Positive Clinical Data from OPGx-BEST1 and OPGx-LCA5 Gene Therapy Programs at Retina in Rio 2026

Opus Genetics, Inc. (IRD) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 Opus Genetics Presents Positive Clinical Data from OPGx-BEST1 and OPGx-LCA5 Gene Therapy Programs at Retina in Rio 2026 OPGx-BEST1 showed improved retinal sensitivity in 75% of evaluable participants in the initial low-dose Cohort 1 of the Company’s Phase 1/2 clinica

SEC EDGAR 8-K2 min
OCT 15
$SMCIMed

Rosenblatt reiterates Buy on Super Micro stock after CFO hire

Rosenblatt reiterated a Buy rating and $51 price target for Super Micro Computer (SMCI) after the company hired Mark Long as CFO, citing reduced governance concerns and growth potential. The firm expects investor focus to shift to growth and margins. Long previously served as CFO at Western Digital. Rosenblatt's target is based on 10 times its FY27 EPS estimate, with earnings estimates up 30% over three months.

investing.com2 min